EAST RUTHERFORD, N.J. -- New York Giants co-owner John Mara revealed Monday that he was recently diagnosed with cancer. Mara, who serves as the team's president and CEO, was at the team's 21-18 win ...

Bryce Vissel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

People affected by Huntington’s disease could at last benefit from the first treatment to slow the fatal neurodegenerative condition. Scientists from University College London (UCL) found patients ...

The Trump administration is touting an old generic drug as a new treatment for autism despite limited evidence, sparking unease among doctors and scientists who say the medication needs to be studied ...

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...

Nick Benz-Bushling never imagined that managing his son’s mental health care would turn into a real-life horror story. After years of struggles, 16-year-old Johnathan attempted suicide in February.

Days after federal immigration agents detained Cary Lopez Alvarado, a 23-year-old Los Angeles native and U.S. citizen, she gave birth to a baby girl. Lopez Alvarado and her now 3-month-old child are ...

Just six months ago, the Trump administration promised to find the cause of autism. On September 22, top U.S. health officials announced both a cause and a treatment — though neither is on solid ...

A gamer seeking financial support for cancer treatment lost $32,000 after downloading from Steam a verified game named BlockBlasters that drained his cryptocurrency wallet. BlockBlasters is a 2D ...

President Donald Trump and his top health aides plan to link a common over-the-counter pain medication to autism and name another drug as a possible treatment for the brain development condition.

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Daniel Payne reports on how the health industry and Washington influence ...

After a tumultuous journey filled with delays and rejection, the FDA has approved Stealth BioTherapeutics’ treatment for the ultrarare disease Barth syndrome, marking the peptide as the first therapy ...